European Union - English - EMA (European Medicines Agency)

celgene europe ltd. - lepirudin - thromboembolism; thrombocytopenia - antithrombotic agents - anticoagulation in adult patients with heparin-induced thrombocytopenia type ii and thromboembolic disease mandating parenteral antithrombotic therapy.the diagnosis should be confirmed by the heparin-induced platelet activation assay or an equivalent test.

Canada - English - Health Canada

bayer inc - lepirudin - powder for solution - 50mg - lepirudin 50mg - direct thrombin inhibitors

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

celgene ltd - lepirudin - powder for solution for injection - 50mg